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Summary Ninety cases of non-Hodgkin's lymphoma diagnosed prior to the use of modern therapeutic
regimens (1963-67) and 88 cases treated with such chemotherapy (1980-85) were studied using conventional
morphology and flow cytometry. DNA aneuploidy as determined by flow cytometry was more common
among high grade (38%) than low grade (19%) tumours (P<0.01). Measurements of proliferative index
(S+G2 phase cells) revealed significantly increased values for high grade as compared with low grade
lymphomas (P<0.001). In the first group of cases (1963-67) the relationship between histological grade and
survival just failed to reach statistical significance over the long term (20yr) (P=0.1) but proved significant
over 3yr (P=0.012). Differences in ploidy and proliferative index status were not associated with survival. In
the second patient group (1980-85) attainment of complete remission following chemotherapy was associated
with the presence of DNA aneuploidy in high grade tumours (P<0.05). The limited follow up of this group
precluded assessment of survival in relation to ploidy.
The classification of non-Hodgkin's lymphomas
(NHL) using conventional morphology has resulted
in poor reproducibility reflecting the inherently
subjective nature of morphological assessments
(Bird, et al., 1984). This has lead to a search for
more objective methods for classifying NHL and
predicting their behaviour. Measurement of DNA
content by flow cytometry has recently been found
to be of considerable value in predicting the
behaviour of various types of solid tumour
(Friedlander, et al., 1984a,b; Armitage et al., 1985).
When applied to NHL it has been found that DNA
content correlates well with the morphological
subdivision of tumours into low and high categories
(Diamond et al., 1982; Shackney et al., 1984;
Stringley et al., 1985). However, this work was
carried out prospectively using fresh tissue
precluding any correlations with long term survival.
The recent development of techniques to analyse
the DNA content of tumours processed to paraffin
(Hedley et al., 1983) provides an opportunity to
undertake such studies on a retrospective basis. We
have therefore undertaken such an investigation
and have also examined whether the DNA content
of tumours influences their response to chemo-
therapy.
Materials and methods
Tissue studied
Paraffin blocks from 90 randomly selected cases of
NHL received in the Pathology Departments at
Leeds University, York District General Hospital
and Hull Royal Infirmary during 1963-67, together
with 88 cases referred to the Yorkshire Regional
Lymphoma Panel during 1980-85 were retrieved for
study. The tissue had been fixed in 10% neutral
phosphate buffered formalin.
Morphological assessment
Haematoxylin and eosin (H&E) stained sections
(4,um) were prepared and lymphomas categorized
morphologically according to the Kiel classification
(Lennert, 1978).
Flow cytometry
Nuclear DNA measurements were performed using
a modification of the method of Hedley et al.
(1983). Fifty gm sections were cut from paraffin
embedded blocks and transferred to glass slides.
The sections were dewaxed in xylene and
rehydrated by passing through a series of alcohols
(100%, 95%, 90%, 70% and 50%). The sections
were washed twice in distilled water, the tissue
removed with a scalpel and placed in a test tube
with 0.5% pepsin (Sigma Chemical Company,
Poole, BH17 7NH) in 0.9% NaCl adjusted to
pH 1.5 with 2N HC1, and incubated at 37°C for
30min in a waterbath. The cells were centrifuged
at 2000 r.p.m. washed twice in distilled water
and stained by suspending in a solution of
(1 Mgml-1) of 4',6'-diamidino-2-phenylindole-
dihydrochloride (Boehringer Mannheim, West
Germany) in RPMI 1640 culture medium- at 20°C
for 30min before filtering through four layers of
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butter muslin and syringing through a 23 gauge
needle. Samples were analysed on an EPICS V
flow cytometer (Coulter Electronics, Hialeh, Florida,
USA). For excitation a Coherent Innova - 90 5W
UV enhanced argon ion laser was used at 50mw at
a wavelenth of 350nm. A 408nm interference filter
removed scattered incident ultraviolet fluorescence.
Ten thousand nuclei were counted.
Detection and quantitation ofDNA aneuploidy by
flow cytometry
The criterion for detection of DNA aneuploidy was
the presence of more than one GO/Gl peak
(Hiddemann et al., 1984) (Figure 1). The degree of
DNA aneuploidy was expressed as the DNA index,
where the DNA index=modal channel number of
the DNA aneuploid GO/Gl peak divided by the
peak modal channel number of the diploid GO/Gl
peak.
Determination offraction ofcells in S and G2 phase
(proliferative index)
Cell cycle analysis was performed by the method of
Bagwell et al., 1979. The S phase and G2
compartments were combined to determine the
proliferative index. Calculation of the S and G2
fractions of the DNA aneuploid tumours was not
performed due to overlap of the cell populations.
Survival data and statistics
Survival data for the cases diagnosed between 1963
and 1967 was obtained through the Yorkshire
Regional Cancer Registry. Survival time was
calculated from the time of diagnosis to the last
follow-up date or date of death. Possible
associations between morphological and flow
cytometric assessments in all 178 cases and between
morphology, flow cytometry and survival in the
1963 to 1967 cases was carried out using x2 test,
Wilcox rank test for unpaired data and log rank
survival analysis (Peto et al., 1976). In
morphologically defined high grade cases diagnosed
between 1980 and 1985 information concerning
attainment of complete clinical remission was
obtained from patients' case notes. Complete
remission was defined as absence of clinical
symptoms and signs, a blood count within normal
limits and a normal CAT scan and bone marrow.
Analysis of the relationship between DNA content
and complete remission was carried out using a
two-tailed Fisher's exact test. To relate DNA index
and proliferative index in the 1963 to 1967 cases to
survival the cases were allocated to groups on the
basis of the index value. DNA aneuploid cases were
separated into those with a DNA index of 1.8 to
2.2 (DNA tetraploid tumours) and those whose
DNA index fell outside this range. Cases with a
proliferative index >20% were regarded as having
a 'high' value, the remainder were considered 'low'
values. The cut off value of 20% was the mean
proliferative index of all 90 cases diagnosed
between 1963 and 1967. In addition survival was
assessed using proliferative index at differing cut off
points. The cut off points ranged from 5 to 30%
increasing at 5% intervals.
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Figure 1 DNA histogram of (a) diploid and (b) DNA
aneuploid tumours.
Results
Clinical and morphologicalfindings
Of the 178 patients 99 were male giving a
male:female ratio of 1.2:1 and the age range at
presentation was 7-86yr with a mean of 58.3yr. At
the time survival data was calculated, only 7
patients first diagnosed during 1963-67 remained
alive as compared with 57 of those diagnosed
during 1980-85. One hundred and thirty-one casesl|EsXW-bS- .- -- ,
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presented primarily with lymph node based disease
whilst the majority of extranodal cases arose in
skin. The morphological classification of cases
using the Kiel system is summarized in Table I.
One hundred and six cases were low grade and 72
high grade in type.
tumours than among low grade tumours
(P<0.001).
The relationship of morphological grade
Table I Morphological classification and ploidy status of 178 cases non-Hodgkin's lymphoma.
Classificationa No. cases (%) No. aneuploid (%)
Low grade
ML, Lymphocytic
ML, Centrocytic
ML, Centroblastic/centrocytic
Follicular
Follicular and diffuse
Diffuse
High grade
ML, Centroblastic
ML, Lymphoblastic
ML, Immunoblastic
ML, High grade, not otherwise specified
ML, Mycosis fungoides
TOTAL
34 (19)
17 (10)
26
13
16
(15)
(7)
(9)
13 (7)
14 (8)
4 (2)
38 (21)
3 (2)
178 (100.0)
aKiel classification (Lennert, 1978). ML=Malignant lymphoma.
DNA analysis
The results of DNA analysis of DNA ploidy
content of the 178 cases are summarized in Table I.
The mean half peak coefficient of variation of
diploid cases was 6.4% as measured by standard
software (Coulter Electronics, Hialeh, Florida,
USA). Forty-seven of 178 (26%) of cases showed
evidence of DNA aneuploidy. The greatest number
of DNA aneuploid cases was observed among high
grade lymphomas (27/72; 38%) with significantly
fewer cases (20/106; 19%) occuring in low grade
lymphomas (P<0.01). There was no significant
association between sex and age of patient, or
nodal and extranodal status of lymphoma and
ploidy values. Analysis of the DNA index of DNA
aneuploid cases revealed a bimodal distribution of
DNA content with a tendency to cluster around
DNA indices of 1.3 and 2 (Figure 2).
Proliferative index
The distribution of proliferative index among
lymphomas is shown in Figure 3. Low grade
lymphomas had lower mean values (15.7%) than
high grade tumours (24.24%). The mean
proliferative index of all 178 cases was 19%. Cases
with a proliferative index of 19% and above were
found significantly more often among high grade
lymphoma, ploidy status, DNA index and
proliferative index to survival was assessed in the
cases diagnosed during 1963-67. The survival data
was absolute and not corrected for age. The
association between morphological grade of NHL
and survival assessed using long rank statistics over
the whole 20 yr period approached significance
(P=0.1) (Figure 4). Assessment at 3yr and 7yr
respectively using x2 test revealed significant results
at 3yr (P=0.01) but not at 7yr (P=0.07). Neither
ploidy, DNA index nor proliferative index were
associated with survival (see Figures 5 and 6) when
assessed over the whole 20yr period (log rank test)
or in the short term (3 yr; x2 test). The latter three
variables still gave non-significant differences in
survival when controlled for grade using the log
rank test even when variable proliferative indices
were employed as described by Roos et al. (1985).
Clinical remission andploidy
The relationship between DNA content of the 23
high grade tumours diagnosed during 1980-85 and
the achievement of complete clinical remission was
assessed. Whilst complete remission was obtained in
6/6 (100%) DNA aneuploid cases only 7/17 (41%)
of the diploid cases achieved this result (P<0.05).
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Figure 2 Distribution of ploidy indices (DNA index) among DNA aneuploid cases.
Analysis of the difference in remission rate between
high grade lymphomas with high and low
proliferative indices failed to reach statistical
significance. There was insufficient follow up time
to analyse the 1980-85 data for association with
* survival.
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Figure 3 Distribution of proliferative index (% cells
in S+G2) in high and low grade tumours, mean
value.
Discussion
Although a number of workers have documented
the relationship between the morphological grade of
NHL and DNA content (Shackney et al., 1984;
Braylan et al., 1984), no previous study has been
able to determine the significance of differences in
DNA content in relation to long term survival. In
this study we have shown that statistically
significant differences in frequency of DNA
aneuploidy between low and high grade lymphomas
can be demonstrated using paraffin embedded
material. However, the present study has failed to
demonstrate that assessment of ploidy status
provides a better prognostic indicator than
morphological grade. Indeed, the survival curves
reveal no differences between DNA aneuploid and
diploid tumours, even when differences in grade
were taken into account. Concerning analysis of
survival of NHL according to grade, this only
approached significance when assessed over 20yr,
however survival at 3 yr proved significant. The
survival curves according to grade (Figure 4) show
great similarity to those produced by workers in
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Figure 4 Cumulative survival curve according to grade of non-Hodgkin's lymphoma. (-), high grade;
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Figure 6 Cumulative survival curve in relation to proliferative index above or below 20%. (-) >20%;
( ), <20%.
Kiel (Brittinger et al., 1984). However the low and
high grade curves merge at a later stage in the
present study. This probably reflects differences in
therapeutic regimens.
It should be realized the retrospective nature of
the study precluded evaluation of the influence of
such factors as stage of lymphoma and hetero-
geneity of DNA content within individual tumours.
It will be necessary to consider these factors in
prospective studies.
Long tcrm survival data was only available in the
1963-67 cases when treatment consisted largely of
radiotherapy with only a small proportion of
patients receiving cyclophosphamide therapy in
addition. However, the observation in this study
with patients from a later period (1980-85), that
high grade DNA aneuploid tumours treated with
modern combination chemotherapy, show a high
rate of complete remission is of considerable
interest. Similar findings have been made in
infantile neuroblastomas (Look et al., 1984) and
childhood acute lymphoblastic leukaemias (Look et
al., 1983). Whether such enhanced susceptibility to
chemotherapy will result in a more prolonged
survival or freedom from relapse has yet to be
determined. It is interesting to speculate that there
may be a link between cell survival and the effective
action of the cytotoxic agents relating to DNA
content.
Measurement of DNA index in the DNA
aneuploid tumours revealed a bimodal distribution
confirming the findings of others (Braylan et al.,
1984; Shackney et al., 1984). It has been suggested
that some diploid tumours become DNA tetraploid
with subsequent development of cytogenetic
instability and chromosome loss to become DNA
aneuploid tumours. The chromosome loss is
believed to accompany an increase in tumour
aggressiveness in keeping with the clonal evolution
theory (Nowell, 1976). For this reason some
workers suggest DNA tetraploid tumours may have
a better prognosis than DNA aneuploid tumours
(Bunn et al., 1980; Isaacs et al., 1982). We have not
been able to confirm this suggestion in this study.
Previous investigations (Braylan et al., 1984;
Diamond et al., 1982; Shackney et al., 1984) using
fresh tissue have shown that the proportion of
tumour cells in S phase of the cell cycle correlates
with the lymphoma morphological grade. Our
results confirm this finding using reprocessed
paraffin embedded material. Using a combination
of S+G2 as a measure of the proliferative index
and a cut off point of 19% (mean value for all
cases), the majority of low grade lymphomas were
found to lie below this value whereas most high
grade tumours were above. Recent work has
suggested that in the short term (2-3yr) pro-
liferative index correlates with survival (Roos et al.,
1985). The present study does not confirm these
findings over a similar period of time (3 yr) or over
a longer period of time (15-20yr). An explanation
for this may lie in the different modes of therapy
applied to the two groups.
The finding that the presence of DNA
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aneuploidy in high grade lymphomas treated with
aggressive chemotherapy is associated with a high
rate of first remission may have considerable
clinical implications. There is now an urgent need to
follow this further to determine the importance of
DNA content as regards its influence on future
therapy.
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